A Study of HBM9161 in NMOSD Patients

NCT04227470 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

NMO Spectrum Disorder

Interventions

DRUG: HBM9161 Injection

Sponsor

Harbour BioMed (Guangzhou) Co. Ltd.